Expression of steroid hormone receptors in BRCA1-associated ovarian carcinomas

Gynecologic Oncology

Volumn 97, Issue 1, 2005, Pages 16-25

  Aghmesheh, Morteza ^a,b,c   Edwards, Lyndal ^a   Clarke, Christine L ^c,d,e   Byth, Karen ^e   Katzenellenbogen, Benita S ^f   Russell, Pamela J ^a,b   Friedlander, Michael ^a,c   Tucker, Katherine M ^a,c   De Fazio, Anna ^d,e,g  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Kathleen Cuningham Consortium R   (United States)

^d WESTMEAD HOSPITAL   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^g WESTMEAD HOSPITAL   (Australia)

Author keywords

Androgen receptor; BRCA1; Estrogen receptor; Ovarian carcinoma; Progesterone receptor

Indexed keywords

ANDROGEN RECEPTOR; BRCA1 PROTEIN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; PROGESTERONE RECEPTOR A; PROGESTERONE RECEPTOR B; RECEPTOR SUBTYPE; STEROID RECEPTOR; TUMOR PROTEIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER GENETICS; CANCER GRADING; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HETEROZYGOTE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TUMOR SUPPRESSOR GENE;

EID: 15544379659     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.12.030     Document Type: Article

References (68)

1. Y. Chen, W. Lee, and H.K. Chew Emerging roles of BRCA1 in transcriptional regulation and DNA repair J. Cell. Physiol. 181 1999 385 392
2. S. Fan, J.A. Wang, R. Yuan, Y. Ma, Q. Meng, and M.R. Erdos BRCA1 inhibition of estrogen receptor signaling in transfected cells Science 284 1999 1354 1356
3. L. Zheng, L.A. Annab, C.A. Afshari, W.H. Lee, and T.G. Boyer BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor Proc. Natl. Acad. Sci. U. S. A. 98 2001 9587 9592
4. S. Fan, Y.X. Ma, C. Wang, R.Q. Yuan, Q. Meng, and J.A. Wang Role of direct interaction in BRCA1 inhibition of estrogen receptor activity Oncogene 20 2001 77 87
5. J.J. Park, R.A. Irvine, G. Buchanan, S.S. Koh, J.M. Park, and W.D. Tilley Breast cancer susceptibility gene 1 (BRCA1) is a coactivator of the androgen receptor Cancer Res. 60 2000 5946 5949
6. S. Yeh, Y.C. Hu, M. Rahman, H.K. Lin, C.L. Hsu, and H.J. Ting Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells Proc. Natl. Acad. Sci. U. S. A. 97 2000 11256 11261
7. T.R. Rebbeck, P.W. Kantoff, K. Krithivas, S. Neuhausen, M.A. Blackwood, and A.K. Godwin Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat Am. J. Hum. Genet. 64 1999 1371 1377
8. J.V. Rajan, S.T. Marquis, H.P. Gardner, and L.A. Chodosh Developmental expression of BRCA2 colocalizes with BRCA1 and is associated with proliferation and differentiation in multiple tissues Dev. Biol. 184 1997 385 401
9. W.Y. Huang, B. Newman, R.C. Millikan, M.J. Schell, B.S. Hulka, and P.G. Moorman Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status Am. J. Epidemiol. 151 2000 703 714
10. N. Loman, O. Johannsson, P.O. Bendahl, A. Borg, M. Ferno, and H. Olsson Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes Cancer 83 1998 310 319
11. S.R. Lakhani, J. Jacquemier, J.P. Sloane, B.A. Gusterson, T.J. Anderson, and M.J. van de Vijver Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations J. Natl. Cancer Inst. 90 1998 1138 1145
12. S.R. Lakhani, M.J. van de Vijver, J. Jacquemier, T.J. Anderson, L. McGuffog, and D.F. Easton The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2 J. Clin. Oncol. 20 2002 2310 2318
13. S.R. Lakhani, S. Manek, F. Penault-Llorca, A. Flanagan, L. Arnout, and S. Merrett Pathology of ovarian cancers in BRCA1 and BRCA2 carriers Clin. Cancer Res. 10 7 2004 2473 2481
14. S.C. Rubin, I. Benjamin, K. Behbakht, H. Takahashi, M.A. Morgan, and V.A. Li Volsi Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1 N. Engl. J. Med. 335 19 1996 1413 1416
15. J. Chang, I. Fryatt, B. Ponder, C. Fisher, and M.E. Gore A matched control study of familial epithelial ovarian cancer: patient characteristics, response to chemotherapy and outcome Ann. Oncol. 6 1 1995 80 82
16. X. Chen, and Y. Feng Effect of progesterone combined with chemotherapy on epithelial ovarian cancer Chin. Med. J. (Engl) 116 3 2003 388 391
17. O.T. Johannsson, I. Idvall, C. Anderson, A. Borg, R.B. Barkardottir, and V. Egilsson Tumour biological features of BRCA1-induced breast and ovarian cancer Eur. J. Cancer 33 3 1997 362 371
18. P.D. Pharoah, D.F. Easton, D.L. Stockton, S. Gayther, and B.A. Ponder Survival in familial, BRCA1-associated, and BRCA2-associated epithelial ovarian cancer. United kingdom coordinating committee for cancer research (UKCCCR) familial ovarian cancer study group Cancer Res. 59 4 1999 868 871
19. I. Cass, R.L. Baldwin, T. Varkey, R. Moslehi, S.A. Narod, and B.Y. Karlan Improved survival in women with BRCA-associated ovarian carcinoma Cancer 97 2003 2187 2195 [New York, NY, United States]
20. J. Boyd, Y. Sonoda, M.G. Federici, F. Bogomolniy, E. Rhei, and D.L. Maresco Clinicopathological features of BRCA-linked and sporadic ovarian cancer JAMA 283 17 2000 1 18
21. R.E. Buller, M.S. Shahin, J.P. Geisler, M. Zogg, B.R. DeYoung, and C.S. Davis Failure of BRCA1 dysfunction to alter ovarian cancer survival Clin. Cancer Res. 8 5 2002 1196 1202
22. O.T. Johannsson, J. Ranstam, A. Borg, and H. Olsson Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden J. Clin. Oncol. 16 2 1998 397 404
23. S.J. Ramus, P.D.P. Pharoah, P. Harrington, C. Pye, B. Werness, and L. Bobrow BRCA1/2 mutation status influences somatic genetic progression in inherited and sporadic epithelial ovarian cancer cases Cancer Res. 63 2 2003 417 423
24. Y. Patael-Karasik, M. Daniely, W.H. Gotlieb, G. Ben-Baruch, J. Schiby, and G. Barakai Comparative genomic hybridization in inherited and sporadic ovarian tumours in Israel Cancer Genet. Cytogenet. 121 2000 26 32
25. A.A. Jazaeri, C.J. Yee, C. Sotiriou, K.R. Brantley, J. Boyd, and E.T. Liu Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers J. Natl. Cancer Inst. 94 2002 990 1000
26. H.A. Risch Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone J. Natl. Cancer Inst. 90 1998 1774 1786
27. C. La Vecchia, A. Decarli, S. Franceschi, M. Regallo, and G. Tognoni Age at first birth and the risk of epithelial ovarian cancer J. Natl. Cancer Inst. 73 1984 663 666
28. A.P. Makar Hormone therapy in epithelial ovarian cancer Endocr. Relat. Cancer 7 2000 85 93
29. N.G. Hildreth, J.L. Kelsey, V.A. LiVolsi, D.B. Fischer, T.R. Holford, and E.D. Mostow An epidemiologic study of epithelial carcinoma of the ovary Am. J. Epidemiol. 114 1981 398 405
30. T.J.A. Key, J. Chen, D.Y. Wang, M.C. Pike, and J. Boreham Sex hormones in women in rural China and in Britain Br. J. Cancer 62 1990 631 636
31. M.C. Pike, and D.V. Spicer Contraception D.S.F. Haseltine Oral contraceptives and cancer 1993 Springer-Verlag New York 67 84
32. J. Akahira, T. Inoue, T. Suzuki, K. Ito, R. Konno, and S. Sato Progesterone receptor isoforms A and B in human epithelial ovarian carcinoma: immunohistochemical and RT-PCR studies Br. J. Cancer 83 2000 1488 1494
33. M.R. Cardillo, E. Petrangeli, N. Aliotta, L. Salvatori, L. Ravenna, and C. Chang Androgen receptors in ovarian tumors: correlation with estrogen and progesterone receptors in an immunohistochemical and semiquantitative image analysis study J. Exp. Clin. Cancer Res. 17 1998 231 237
34. S.P. Langdon, H. Gabra, J.M.S. Bartlett, G.J. Rabiaz, R.A. Hawkins, and A.L. Tesdale Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogen Clin. Cancer Res. 4 1998 2245 2251
35. K.M. Lau, S.C. Mok, and S.M. Ho Expression of human estrogen receptor-α and-β, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells Proc. Natl. Acad. Sci. U. S. A. 96 1999 5722 5727
36. K. Munstedt, J. Steen, A.G. Knauf, T. Buch, R. von Georgi, and F.E. Franke Steroid hormone receptors and long term survival in invasive ovarian cancer Cancer 89 2000 1783 1791
37. H.C. van Doorn, C.W. Burger, P. van der Valk, and H.M.G. Bonfrer Estrogen, progesterone, and androgen receptors in ovarian neoplasia: correlation between immunohistochemical and biochemical receptor analyses J. Clin. Pathol. 53 2000 201 205
38. A.W. Brandenberger, M.K. Tee, and R.B. Jaffe Estrogen receptor alpha (ER-α) and beta (ER-β) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down-regulation of ER-β in neoplastic tissues J. Clin. Endocrinol. Metab. 83 1998 1025 1028
39. B.S. Katzenellenbogen Mechanisms of action and cross-talk between estrogen receptor and progesterone receptor pathways J. Soc. Gynecol. Investig. 7 Suppl 1 2000 S33 S37
40. P. Kastner, A. Krust, B. Turcotte, U. Stropp, L. Tora, and H. Gronemeyer Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B EMBO J. 9 1990 1603 1614
41. L.J. Havrilesky, C.P. McMahon, E.K. Lobenhofer, R. Whitaker, J.R. Marks, and A. Berchuck Relationship between expression of coactivators and corepressors of hormone receptors and resistance of ovarian cancers to growth regulation by steroid hormones J. Soc. Gynecol. Investig. 8 2001 104 113
42. H.A. Risch, J.R. McLaughlin, D.E.C. Cole, B. Rosen, L. Bradley, and E. Kwan Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer Am. J. Hum. Genet. 68 2001 700 710
43. P.A. Mote, J.F. Johnston, T. Manninen, P. Tuohimaa, and C.L. Clarke Detection of progesterone receptor forms A and B by immunohistochemical analysis J. Clin. Pathol. 54 2001 624 630
44. I. Choi, C. Ko, O.K. Park-Sarge, R. Nie, R.A. Hess, and C. Graves Human estrogen receptor beta-specific monoclonal antibodies: characterization and use in studies of estrogen receptor beta protein expression in reproductive tissues Mol. Cell. Endocrinol. 181 2001 139 150
45. C.L. Clarke, R.J. Zaino, P.D. Feil, J.V. Miller, M.E. Steck, and B.M. Ohlsson-Wilhelm Monoclonal antibodies to human progesterone receptor: characterization by biochemical and immunohistochemical techniques Endocrinology 121 1987 1123 1132
46. J.L. Yang, K.T. Ow, P.J. Russell, J.M. Ham, and P.J. Crowe Higher expression of oncoproteins c-myc, c-erbB-2/neu, PCNA, and p53 in metastasizing colorectal cancer than in nonmetastasizing tumors Ann. Surg. Oncol. 3 1996 574 579
47. R. Yancik Ovarian cancer. Age contrasts in incidence, histology, disease stage at diagnosis, and mortality Cancer 71 Suppl 2 1993 S517 S523
48. G.P. Skliris, P.J. Carder, M.R.J. Lansdown, and V. Speirs Immunohistochemical detection of ER-β in breast cancer: towards more detailed receptor profiling? Br. J. Cancer 84 2001 1095 1098
49. R.E. Hall, C.S.L. Lee, I.E. Alexander, J. Shine, C.L. Clarke, and R.L. Sutherland Steroid hormone receptor gene expression in human breast cancer cells: inverse relationship between estrogen and glucocorticoid receptor messenger RNA levels Int. J. Cancer 46 1990 1081 1087
50. K.B. Horwitz, Y. Koseki, and W.L. McGuire Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen Endocrinology 103 1978 1742 1751
51. S.A. Narod, H. Risch, R. Moslehi, A. Dorum, S. Neuhausen, and H. Olsson Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group N. Engl. J. Med. 339 1998 424 428
52. S.A. Narod, P. Sun, P. Ghadirian, H. Lynch, C. Isaacs, and J. Garber Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study Lancet 357 2001 1467 1470
53. A. Berchuck, K.-A. Heron, M.E. Carney, J.M. Lancaster, E.G. Fraser, and V.L. Vinson Frequency of germline and somatic BRCA1 mutations in ovarian cancer Clin. Cancer Res. 4 1998 2433 2437
54. T.A. Lallas, T.E. Buekers, and R.E. Buller BRCA1 mutations in familial ovarian cancer Mol. Genet. Metab. 67 1999 357 363
55. S.D. Merajver, T.M. Pham, R.F. Caduff, M. Chen, E.L. Poy, and K.A. Cooney Somatic mutations in the BRCA1 gene in sporadic ovarian tumors Nat. Genet. 9 1995 439 443
56. R.L. Baldwin, E. Nemeth, H. Tran, H. Shvartsman, I. Cass, and S. Narod BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study Cancer Res. 60 2000 5329 5333
57. J.P. Geisler, M.A. Hatterman-Zogg, J.A. Rathe, and R.E. Buller Frequency of BRCA1 dysfunction in ovarian cancer J. Natl. Cancer Inst. 94 2002 61 67
58. P.A. Russell, P.D.P. Pharoah, K. De Foy, S.J. Ramus, I. Symmonds, and A. Wilson Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers Int. J. Cancer 87 2000 317 321
59. W. Zheng, F. Luo, J.J. Lu, A. Baltayan, M.F. Press, and Z. Zhang Reduction of BRCA1 expression in sporadic ovarian cancer Gynecol. Oncol. 76 2000 294 300
60. N. Auersperg, M.I. Edelson, S.C. Mok, S.W. Johnson, and T.C. Hamilton The biology of ovarian cancer Semin. Oncol. 25 1998 281 304
61. S. Chadha, B.R. Rao, B.J. Slotman, C.C.J. van Vroonhoven, and T.H. van der Kwast An immunohistochemical evaluation of androgen and progesterone receptors in ovarian tumors Hum. Pathol. 24 1993 90 95
62. P. Pujol, J.M. Rey, P. Nirde, P. Roger, M. Gastaldi, and F. Laffargue Differential expression of estrogen receptor-α and-β messenger RNAs as a potential marker of ovarian carcinogenesis Cancer Res. 58 1998 5367 5373
63. K. Paech, P. Webb, G.G.J.M. Kuiper, S. Nilsson, J.A. Gustafsson, and P.J. Kushner Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites Science 277 1997 1508 1510
64. T. Rutherford, W.D. Brown, E. Sapi, S. Aschenazi, A. Munoz, and G. Mor Absence of estrogen receptor-β expression in metastatic ovarian cancer Obstet. Gynecol. 96 2000 417 421
65. A. Bardin, P. Hoffmann, N. Boulle, D. Katsaros, F. Vignon, and P. Pujol Involvement of estrogen receptor beta in ovarian carcinogenesis Cancer Res. 64 16 2004 5861 5869
66. P.A. Mote, S. Bartow, N. Tran, and C.L. Clarke Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis Breast Cancer Res. Treat. 72 2002 163 172
67. R.L. Arnett-Mansfield, A. deFazio, G.V. Wain, R.C. Jaworski, K. Byth, and P.A. Mote Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium Cancer Res. 61 2001 4576 4582
68. A.J. Li, R.L. Baldwin, and B.Y. Karlan Estrogene and progesterone receptor subtype expression in normal and malignant ovarian epithelial cell cultures Am. J. Obstet. Gynecol. 189 2003 22 27